118.50
+0.50
+(0.42%)
At close: January 31 at 7:31:17 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,521,900.00
5,371,400.00
13,577,400.00
889,700.00
-13,500.00
Investing Cash Flow
-5,383,000.00
-6,954,500.00
-35,300.00
-566,100.00
-144,800.00
Financing Cash Flow
-51,500.00
-778,600.00
-1,419,300.00
94,200.00
894,700.00
End Cash Position
9,583,200.00
11,663,700.00
13,875,100.00
1,692,700.00
1,210,200.00
Capital Expenditure
-551,400.00
-705,500.00
-363,300.00
-154,000.00
-85,400.00
Issuance of Capital Stock
--
--
110,500.00
160,900.00
753,000.00
Issuance of Debt
200.00
300.00
800.00
--
156,000.00
Repayment of Debt
-50,900.00
-40,400.00
-59,900.00
-66,700.00
-14,300.00
Repurchase of Capital Stock
-800.00
-738,500.00
-986,400.00
--
--
Free Cash Flow
970,500.00
4,665,900.00
13,214,100.00
735,700.00
-98,900.00
12/31/2020 - 10/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
B1MR34.SA BioMarin Pharmaceutical Inc.
186.90
0.00%
49B.F BeiGene, Ltd.
16.80
+0.60%
REGN34.SA Regeneron Pharmaceuticals, Inc.
65.74
-1.81%
BM8.MU Biomarin Pharmaceutical Inc
61.58
+0.95%
TECH Bio-Techne Corporation
73.55
+1.09%
INO Inovio Pharmaceuticals, Inc.
2.0900
0.00%
NVAX Novavax, Inc.
8.69
-3.55%
MRNA Moderna, Inc.
39.42
-3.95%